Patients’ and Families’ Perceptions of Anti-Amyloid Therapies for Alzheimer’s Disease
Author Information
Author(s): Lucca Kaitlyn, Lapins Allison, Morhardt Darby
Primary Institution: Northwestern University
Hypothesis
This study aims to gain insight into the perceptions, concerns, and perceived barriers from patients and families impacted by Alzheimer’s Disease regarding new drug therapies.
Conclusion
Preliminary results indicate that concerns about medical complications and financial burden are prevalent among patients and families considering anti-amyloid therapies.
Supporting Evidence
- The highest reported concerns with starting anti-amyloid therapies were medical complications and financial burden.
- The majority of participants’ interest levels remained the same or increased after the consultation.
- Some participants reported decreased interest due to concerns about the therapy's impact on daily life.
Takeaway
This study is asking patients and their families what they think about new Alzheimer’s drugs to help them make better choices.
Methodology
Participants completed a survey after a consultation with their behavioral neurologist.
Limitations
The study is ongoing, and additional results will be reported in the coming months.
Participant Demographics
Participants included patients and families impacted by Alzheimer’s Disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website